The safety of antithrombotic therapy during pregnancy

Expert Opinion on Drug Safety

Volumn 3, Issue 2, 2004, Pages 113-118

  Ageno, Walter ^a   Crotti, Stefania ^b   Turpie, Alexander G G ^c  

^a OSPEDALE DI CIRCOLO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Heart valve replacements; Low molecular weight heparin (LMWH); Obstetric complications; Pregnancy; Prophylaxis; Safety; Treatment; Unfractionated heparin (UFH); Venous thromboembolism (VTE); Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN DERIVATIVE; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERY EMBOLISM; BIRTH DEFECT; BLEEDING; BLOOD PLACENTA BARRIER; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; DRUG USE; FETAL HEMORRHAGE; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; OSTEOPOROSIS; PATIENT MONITORING; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK ASSESSMENT; TERATOGENICITY; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM; VERTEBRA FRACTURE; FEMALE; PRACTICE GUIDELINE; VEIN THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VENOUS THROMBOSIS;

EID: 2342624016     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.2.113     Document Type: Review

References (33)

1. MACKLON NS, GREER IA: Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott. Med. J. (1996) 41:83-86.
2. ATHRASH HK, KOONIN LM, LAWSON HW, FRANKS AL, SMITH JC: Maternal morbidity in the United States 1979 - 1986. Obstet. Gynecol. (1990) 76:1055-1060.
3. HOGBERG U, INNALA E, SANDSTROM A: Maternal mortality in Sweden. Obstet. Gynecol. (1995) 84:240-244.
4. NO AUTHORS LISTED: Report on confidential inquiries into maternal deaths in UK 1994 - 1996: HMSO, London (1998):84.
5. JAMES K, LOHR J, DESHMUKH R, CRANLEY JJ: Venous thrombotic complications of pregnancy. Cardiovasc. Surg. (1996) 4:777-782.
6. RUTHERFORD S, MONTORO M, MCGEHEE W, STRONG T: Thromboembolic disease associated with pregnancy: an 11 year review. Am. J. Obstet. Gynecol. (1991) 164:286. Abstract.
7. ELDOR A: The use of low molecular weight heparin for the management of venous thromboembolism in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. (2002) 104:3-13.
8. BAZZAN M, DONVITO V: Low molecular weight heparin during pregnancy. Thromb. Res. (2001) 101:V175-V186.
9. WEG JG: Venous thromboembolism in pregnancy. Semin. Reprod. Crit. Care Med. (1998) 19(3):231-241.
10. GINSBERG JS: Thromboembolism in pregnancy. Thromb. Haemost. (1999) 82(2):620-625.
11. LOCKWOOD CJ: Heritable coagulopathies in pregnancy. Obstet. Gynecol. Surv. (1999) 54(12):754-765.
12. FRIEDERICH PW, SANSON PJ, SIMIONI P et al.: Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann. Intern. Med. (1996) 125:955-960.
13. PRESTON FE, ROSENDAAL F, WALKER ID et al.: Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 348:913-916.
14. GINSBERG JS, BRILL-EDWARDS P, JOHNSTON M et al.: Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross sectional study. Blood (1992) 80:975-980.
15. WONG V, CHENG CH, CHAN KC: Fetal neonatal outcome of exposure to anticoagulants during pregnancy. Am. J. Med. Genet. (1993) 45:17-21.
16. ZAKZOUK MS: The congenital warfarin syndrome. J. Laryngol. Otol. (1986) 100:215-219.
17. GINSBERG JS, HIRSH J, TURNER CD et al.: Risks to the fetus of anticoagulant therapy during pregnancy. Thromb. Haemost. (1989) 61:197-203.
18. BURNS MM: Emerging concepts in the diagnosis and management of venous thromboembolism during pregnancy. J. Thromb. Thrombolysis (2000) 10:59-68.
19. ORME LE, LEWIS M, DE SWIET M et al.: May mothers given warfarin breast-feed their infants? Br. Med. J. (1977) 1:1564-1565.
20. GINSBERG JS, KOWALCHUK G, HIRSH J et al.: Heparin therapy during pregnancy: risks to the fetus and mother. Arch. Intern. Med. (1989) 149:2233-2236.
21. ANDERSON DR, GINSBERG JS, BURROWS R et al.: Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb. Haemost. (1991) 63:248-250.
22. WARKENTIN TE, LEVINE MN, HIRSH J et al.: Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N. Engl. J. Med. (1995) 332:1330-1335.
23. DOUKETIS JD, GINSBERG JS, BURROWS RF et al.: The effects of long-term heparin therapy during pregnancy on bone density. Thromb. Haemost. (1996) 75:254-257.
24. DAHLMAN TC: Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. J. Obstet. Gynecol. (1993) 168:1265-1270.
25. SANSON BJ, LENSING AWA, PRINS MH et al.: Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb. Haemost. (1999) 81:668-672.
26. SHEFRAS J, FARQUHARSON RG: Bone density studies in pregnant women receiving heparin. Eur. J. Obstet. Gynecol. (1996) 65:171-174.
27. GILLIS S, SHUSHAN A, ELDOR A: Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int. J. Gynaecol. Obstet. (1992) 39:297-301.
28. MONREAL M, LAFOZ E, OLIVE A, DEL RIO L, VEDIA C: Comparison of subcutaneous unfractionated, heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb. Haemost. (1994) 71:7-11.
29. IMPERIALE TF, PETRULIS AS: A meta-analysis of low dose aspirin for prevention of pregnancy-induced hypertensive disease. JAMA (1991) 266:260-264.
30. NO AUTHORS LISTED: CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet (1994) 343:619-629.
31. GINSBERG JS, GREER I, HIRSH J: Use of antithrombotic agents during pregnancy. Chest (2001) 119:S122-S131.
32. CHANG WS, ANAND S, GINSBERG JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch. Intern. Med. (2000) 160:191-196.
33. TASK FORCE ON THE MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF THE EUROPEAN SOCIETY OF CARDIOLOGY: Expert consensus document on management of cardiovascular diseases during pregnancy. Eur. Heart J. (2003) 24:761-781.